Impact of 'Recovery' Footwear on Lower Extremity Comfort and Biomechanics

April 1, 2021 updated by: University of Massachusetts, Amherst

The goal of this study is to understand the impact of wearing shoes with a compliant, energy absorbing midsole material, outside of athletic training sessions on the mechanics of movement, performance, and perceived joint pain and stiffness. Advances in material science have led to a wider range of cushioning system material properties and mid and outsole geometries in footwear. While there are many marketing claims about the potential health benefits of this new class of footwear these have not yet been investigated in well-designed scientific studies.

It is hypothesized that the intervention shoe as compared to the control will reduce self-reported joint pain and stiffness, improve ankle plantarflexion function and increase intersegmental foot motion during walking.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Participants will be asked to make 2 visits, 6 weeks apart, to the Umass Biomechanics Lab in the Totman Building at UMass Amherst for gait analysis and biomechanical performance testing.

At the first study visit, participants will be randomly assigned to one of two groups. Participants assigned to the control group will be asked to continue wearing their typical shoes and to complete every two weeks the footwear and injury log provided. Individuals assigned to the intervention group will be provided with 2 styles of the OOFOS recovery shoes, and will be asked to wear the OOFOS slide, sandal and/or closed toe shoes as their primary footwear outside training and competition for the 6 weeks between study visits. Intervention participants will also be asked to complete a daily shoe wear log and a shoe comfort assessment survey every other week.

At each study visit, subjects will be asked to read and sign an Informed Consent Form, and will also be asked questions about their health, exercise, and injury history. To prepare for the data collection, participants will be asked to change into a pair of shorts and tight shirt that will be provided. Anatomic measurements will then be made with a measuring tape, and ankle flexibility will be assessed by manually moving the participant's ankle into the most flexed and most extended position.

Reflective markers will then be placed on subject's feet/shoes, legs, thighs, hips, shoulders, and arms to record 3-D limb kinematics. To place the markers, we will put little circles of double-sided tape on skin or clothing, with reflective balls on the outer side. The position of the reflective markers will be recorded by high-speed infrared cameras surrounding the data collection space. Subjects will also be instrumented with electromyography (EMG) sensors on the skin over muscles of the leg, to measure the activity of those muscles. Before placing the EMG sensors, a small patch of skin will be shaved to ensure the sensor stays in place and captures the signals needed.

Once markers have been placed, subjects will stand in the data collection space to record a standing calibration trial of the markers. The standing calibration trial will be used to create a computer model on which data analysis will be performed. Subjects will then walk on a long walkway with the cameras surrounding it at a both self-selected and a set speed of 1.4 m/s. This will be repeated several times until at least 5 successful trials have been recorded. A successful trial means that the walking speed varies by no more than 5 % from the previous trial. Subjects will perform the walking trials barefoot and in the OOFOS sandal and closed toe shoes.

Following the gait analysis described above, calf muscle strength will be assessed using a dynamometer. The subject will sit with the leg, hips, and torso securely strapped to prevent unwanted movement. Subjects will then preform isometric and dynamic contractions; enough repetitions will be allowed to facilitate learning of the technique required.

The final test will be a maximum vertical jump height test. Subjects will stand in the middle of the motion capture area and jump as high as they can from a standing position.

When the above procedures are completed, the research staff will open the intervention assignment envelope that will determine if you are assigned to the intervention or control group.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Amherst, Massachusetts, United States, 01002
        • Recruiting
        • Musculoskeletal & Orthopedic Biomechanics Laboratory/ University of Massachusetts Amherst
        • Contact:
        • Principal Investigator:
          • Katherine A Boyer, PhD
        • Sub-Investigator:
          • Ericber Jimenez Francisco, PhD
        • Sub-Investigator:
          • Skylar C Holmes, MS
        • Sub-Investigator:
          • Kali E Shamaly, BS
        • Sub-Investigator:
          • Ramzi M Majaj, MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 28 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI 18 - 35 kg/m2.
  • Stiff or cleated footwear athlete on a competitive team.

Exclusion Criteria:

  • Current injury that required absence from one or more practices in the last 3 weeks of regular team practice.
  • Orthotic or other shoe insert used outside of athletic training times.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants assigned to the control group will be asked to continue wearing their typical shoes and to complete every two weeks the footwear and injury log provided
Experimental: Intervention
Individuals assigned to the intervention group will be provided with 2 styles of the OOFOS recovery shoes, and will be asked to wear the OOFOS slide, sandal and/or closed toe shoes as their primary footwear outside training and competition for the 6 weeks between study visits. Intervention participants will also be asked to complete a daily shoe wear log and a shoe comfort assessment survey every other week.
The OOFOS shoes/ sandals are a commercially available footwear with a compliant, energy absorbing midsole material.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Calf Muscles Strength
Time Frame: 2 - 3 hours on week 1
Unilateral isometric and isokinetic strength based on maximal contractions performed on a dynamometer.
2 - 3 hours on week 1
Calf Muscles Strength
Time Frame: 2 - 3 hours on week 6.
Unilateral isometric and isokinetic strength based on maximal contractions performed on a dynamometer.
2 - 3 hours on week 6.
Gait Mechanics
Time Frame: Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s
Gait kinematics during overground walk at preferred speed, and 1.4m/s, evaluated with a motion capture system.
Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s
Gait Mechanics
Time Frame: Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s
Gait kinematics during overground walk at preferred speed, and 1.4m/s, evaluated with a motion capture system.
Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s
Muscle EMG activity
Time Frame: Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s
Unilateral Surface Electromyography of Medial Gastrocnemius, Lateral Gastrocnemius, Vastus Medialis, Vastus Lateralis, Tibialis Anterior, Peroneus Longus, Soleus, Biceps Femoris, and Semitendinosus, during overground walk.
Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s
Muscle EMG activity
Time Frame: Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s
Unilateral Surface Electromyography of Medial Gastrocnemius, Lateral Gastrocnemius, Vastus Medialis, Vastus Lateralis, Tibialis Anterior, Peroneus Longus, Soleus, Biceps Femoris, and Semitendinosus, during overground walk.
Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s
Maximum Vertical Jump
Time Frame: 2 - 3 hours on week 1
Height (m) of center of mass above ground measured by markers place on posterior superior iliac spine.
2 - 3 hours on week 1
Maximum Vertical Jump
Time Frame: 2 - 3 hours on week 6
Height (m) of center of mass above ground measured by markers place on posterior superior iliac spine.
2 - 3 hours on week 6
Self-reported shoe comfort
Time Frame: Week 0, 5 minutes
Shoe wear and comfort log
Week 0, 5 minutes
Self-reported pain, and injury.
Time Frame: Week 0, 5 minutes
Injury and pain log
Week 0, 5 minutes
Self-reported shoe comfort
Time Frame: Week 2, 5 minutes
Shoe wear and comfort log
Week 2, 5 minutes
Self-reported pain, and injury.
Time Frame: Week 2, 5 minutes
Injury and pain log
Week 2, 5 minutes
Self-reported shoe comfort
Time Frame: Week 4, 5 minutes
Shoe wear and comfort log
Week 4, 5 minutes
Self-reported pain, and injury.
Time Frame: Week 4, 5 minutes
Injury and pain log
Week 4, 5 minutes
Self-reported shoe comfort
Time Frame: Week 6, 5 minutes
Shoe wear and comfort log
Week 6, 5 minutes
Self-reported pain, and injury.
Time Frame: Week 6, 5 minutes
Injury and pain log
Week 6, 5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 8, 2021

Primary Completion (Anticipated)

January 31, 2022

Study Completion (Anticipated)

January 31, 2022

Study Registration Dates

First Submitted

March 5, 2021

First Submitted That Met QC Criteria

April 1, 2021

First Posted (Actual)

April 5, 2021

Study Record Updates

Last Update Posted (Actual)

April 5, 2021

Last Update Submitted That Met QC Criteria

April 1, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 1826

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthralgia

Clinical Trials on OOFOS Recovery Footwear

3
Subscribe